{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-264072","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2023-10-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.470480+00:00","generated_at":"2026-06-09T09:31:41.389148+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ResMed Q1 FY2024 revenue up 16% to $1.10B; non-GAAP EPS $1.64 (+9% YoY)","bullets":["Revenue $1,102.3M (+16% YoY); operating income $289.0M (+5%); non-GAAP operating profit +10%.","Diluted EPS $1.49 (GAAP) and $1.64 (non-GAAP, +9% YoY); gross margin 54.4%, down 250 bps.","Operating cash flow $286.3M; company expects to resume share repurchase program in upcoming quarter.","Board declared quarterly dividend of $0.48/share, payable Dec 14, record Nov 9."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-264072","json":"https://secwatch.observer/filing/0001193125-23-264072.json","markdown":"https://secwatch.observer/filing/0001193125-23-264072.md","text":"https://secwatch.observer/filing/0001193125-23-264072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312523264072/0001193125-23-264072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312523264072/d547248d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T09:31:41.389148+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e81d77609018698a4966b279b567930ec11b2d48","claim":"RESMED INC reported financial results for the quarter ended September 30, 2023.","evidence_excerpt":"On October 26, 2023, we issued the press release furnished as Exhibit 99.1. The press release describes the results of our operations for the quarter ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312523264072/0001193125-23-264072-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}